Protein Kinase D Targeting Enhances Imatinib Sensitivity in Leukemia Cells
Researchers have identified protein kinase D as a promising downstream target to enhance imatinib efficacy in chronic myeloid leukemia cells.
Researchers have identified protein kinase D as a promising downstream target to enhance imatinib efficacy in chronic myeloid leukemia cells.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.